Cell Line Development Serum Market Scope And Analysis

Report Code : TIPRE00015863
Category : Life Sciences

No. of Pages : 150

Buy Now

Cell Line Development Serum Market Scope, Growth, Size and Share by 2031

Buy Now

Cell Line Development Serum Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 1.16 Billion
Market Size by 2031	US$ 2.00 Billion
Global CAGR (2023 - 2031)	7.0%
Historical Data	2021-2023
Forecast period	2024-2031
Segments Covered	By Type Fetal Bovine Serum Adult Bovine Serum Porcine Serum Horse Serum Other Animal Serum By Application Bioproduction Drug Discovery Tissue Engineering and Regenerative Medicines Toxicity Testing Academic Research
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Thermo Fisher Scientific Inc MERCK KGaA Cytiva Danaher GE Healthcare Lonza Group HiMedia Laboratories Sartorius PAN Biotech Corning Incorporated European Collection of Cell Cultures ECACC

Cell Line Development Serum Market News and Recent Developments

The Cell Line Development Serum Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for viral antigens and strategies:

BioIVT launched human AB serum product line to supplement cell culture media and facilitate cell and gene therapy development. BioIVT is offering both plasma-derived and off-the-clot serum collected from healthy, male AB blood type donors. All products are sterile, filtered, and ready for cell culture. (Source: BioIVT, Company Website, 2021)
In Feb 2024, Gemini Bioproducts LLC launched a new human AB serum product, GemCellTM Plus Xeno Free, for the cell therapy and regenerative medicine markets. (Source: Biospace, Press Release, 2024)

Cell Line Development Serum Market Report Coverage and Deliverables

The “Cell Line Development Serum Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles